Nkarta, Inc. Earnings Per Share (Basic)
Nkarta, Inc. (NKTX) reported Earnings Per Share (Basic) of -$0.54 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-10
- Nkarta, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.54.
- Nkarta, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.37.
- Nkarta, Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$0.37.
- Nkarta, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.29.
- Nkarta, Inc. earnings per share, basic for fiscal 2025 was -$1.41.
- Nkarta, Inc. earnings per share, basic for fiscal 2024 was -$1.60.
- Nkarta, Inc. earnings per share, basic for fiscal 2023 was -$2.40.
- Nkarta, Inc. earnings per share, basic for fiscal 2022 was -$2.61.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.54 10-Q · filed 2026-08-10 | -$0.92 10-Q · filed 2026-08-10 | -$1.29 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$1.58 derived: net income ÷ weighted average shares · filed 2026-08-10 |
| 2026-03-31 | -$0.37 10-Q · filed 2026-05-12 | -$0.74 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$1.04 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$1.35 derived: net income ÷ weighted average shares · filed 2026-08-10 |
| 2025-12-31 | -$0.37 derived: net income ÷ weighted average shares · filed 2026-04-23 | -$0.66 derived: net income ÷ weighted average shares · filed 2026-04-23 | -$0.97 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$1.41 10-K · filed 2026-03-25 |
| 2025-09-30 | -$0.29 10-Q · filed 2025-11-10 | -$0.60 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$1.04 10-Q · filed 2025-11-10 | -$1.39 derived: net income ÷ weighted average shares · filed 2026-08-10 |
| 2025-06-30 | -$0.31 10-Q · filed 2026-08-10 | -$0.74 10-Q · filed 2026-08-10 | -$1.10 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$1.48 derived: net income ÷ weighted average shares · filed 2026-08-10 |
| 2025-03-31 | -$0.43 10-Q · filed 2026-05-12 | -$0.79 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$1.17 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$1.51 derived: net income ÷ weighted average shares · filed 2026-08-10 |
| 2024-12-31 | -$0.35 derived: net income ÷ weighted average shares · filed 2026-04-23 | -$0.74 derived: net income ÷ weighted average shares · filed 2026-04-23 | -$1.08 derived: net income ÷ weighted average shares · filed 2026-04-23 | -$1.60 10-K · filed 2026-03-25 |
| 2024-09-30 | -$0.39 10-Q · filed 2025-11-10 | -$0.73 derived: net income ÷ weighted average shares · filed 2025-11-10 | -$1.26 10-Q · filed 2025-11-10 | -$1.79 derived: net income ÷ weighted average shares · filed 2025-11-10 |
| 2024-06-30 | -$0.34 10-Q · filed 2025-08-12 | -$0.88 10-Q · filed 2025-08-12 | -$1.42 derived: net income ÷ weighted average shares · filed 2025-11-10 | -$1.94 derived: net income ÷ weighted average shares · filed 2025-11-10 |
| 2024-03-31 | -$0.58 10-Q · filed 2025-05-14 | -$1.15 derived: net income ÷ weighted average shares · filed 2025-11-10 | -$1.67 derived: net income ÷ weighted average shares · filed 2025-11-10 | -$2.35 derived: net income ÷ weighted average shares · filed 2025-11-10 |
| 2023-12-31 | -$0.57 derived: net income ÷ weighted average shares · filed 2025-03-26 | -$1.09 derived: net income ÷ weighted average shares · filed 2025-03-26 | -$1.77 derived: net income ÷ weighted average shares · filed 2025-03-26 | -$2.40 10-K · filed 2025-03-26 |
| 2023-09-30 | -$0.52 10-Q · filed 2024-11-07 | -$1.20 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$1.83 10-Q · filed 2024-11-07 | -$2.50 derived: net income ÷ weighted average shares · filed 2024-11-07 |
| 2023-06-30 | -$0.68 10-Q · filed 2024-08-13 | -$1.31 10-Q · filed 2024-08-13 | -$1.98 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$2.56 derived: net income ÷ weighted average shares · filed 2024-11-07 |
| 2023-03-31 | -$0.63 10-Q · filed 2024-05-09 | -$1.30 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$1.88 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$2.49 derived: net income ÷ weighted average shares · filed 2024-11-07 |
| 2022-12-31 | -$0.67 derived: net income ÷ weighted average shares · filed 2024-03-21 | -$1.25 derived: net income ÷ weighted average shares · filed 2024-03-21 | -$1.86 derived: net income ÷ weighted average shares · filed 2024-03-21 | -$2.61 10-K · filed 2024-03-21 |
| 2022-09-30 | -$0.58 10-Q · filed 2023-11-09 | -$1.20 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$1.94 10-Q · filed 2023-11-09 | -$2.63 derived: net income ÷ weighted average shares · filed 2023-11-09 |
| 2022-06-30 | -$0.61 10-Q · filed 2023-08-10 | -$1.38 10-Q · filed 2023-08-10 | -$2.07 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$2.75 derived: net income ÷ weighted average shares · filed 2023-11-09 |
| 2022-03-31 | -$0.79 10-Q · filed 2023-05-11 | -$1.48 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$2.16 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$2.82 derived: net income ÷ weighted average shares · filed 2023-11-09 |
| 2021-12-31 | -$0.69 derived: net income ÷ weighted average shares · filed 2023-03-16 | -$1.37 derived: net income ÷ weighted average shares · filed 2023-03-16 | -$2.03 derived: net income ÷ weighted average shares · filed 2023-03-16 | -$2.62 10-K · filed 2023-03-16 |
| 2021-09-30 | -$0.68 10-Q · filed 2022-11-09 | -$1.34 derived: net income ÷ weighted average shares · filed 2022-11-09 | -$1.93 10-Q · filed 2022-11-09 | |
| 2021-06-30 | -$0.66 10-Q · filed 2022-08-11 | -$1.25 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |